In recent years, young girls in China have been having sex early, and clinically, there was a case where a young girl repeatedly tried forbidden sex, and then due to the abnormality of secretion, she went to the clinic for examination and was found to have a high degree of cervical precancerous lesions; as a matter of fact, the main cause of cervical precancerous lesions is closely related to the transmission of the human papillomavirus (HPV) through sexual intercourse, and the number of cases among young people is also continuously rising, which should not be ignored. The main cause of cervical pre-cancer is related to sexual transmission of human papillomavirus (HPV).
New human papillomavirus test, good preventionHu Guangjun, director of the Taipei Health Screening Center at MHMH, said that the MHMH has continued to be a gatekeeper of women's health since its inception in 1991, and that it has introduced a new human papillomavirus test, in addition to the smear test, as the first line of cervical cancer screening tools. The newest addition is a new test that will be used for the first time for cervical cancer screening, which will help reduce the risk of cervical cancer.
Zhang Zhilong, director of the Department of Gynecological Cancer, Maternity Division, Makai Memorial Hospital, said that pre-cancerous changes in the cervix do not necessarily have signs, and can only be prevented through regular screenings; the smear is mainly to check whether the cervical cell pattern is abnormal, and human papillomavirus test can detect whether the infection of high-risk type of HPV in the cervical cells before the lesions occur; in addition, compared with the previous test, the new HPV DNA test can simultaneously know whether the infection of carcinogenicity. The new HPV DNA test is able to synchronize the HPV types 16 and 18, which are the most carcinogenic, with each other," he said.
Director Chi-Lung Chang explains, according to the results of a large-scale foreign study, about 17% of women infected with HPV type 16 are at risk of high cervical pre-cancer within 10 years, and type 18 also has a 13% chance of lesions; and the new HPV DNA test can detect HPV type 16 and type 18 and other high-risk types of viruses, and uncover pre-cancerous lesions with a sensitivity of up to 95%, which can make up for the lack of a clearer picture of what is going on in a smear test, as well as the lack of a clearer picture of what is going on in the cervix. The new HPV DNA test has a sensitivity of up to 95% to detect pre-cancerous lesions, and can make up for the false negatives caused by the way the test is performed, the transportation of the test results, the preservation of the test results, and even the interpretation of the test results.
Previously, the HPV vaccine also requires screening, and regular testing is guaranteedMany people mistakenly believe that the HPV vaccine (cervical cancer vaccine) does not require regular screening, but the HPV vaccine does not prevent all the high-risk types of HPV. The risk of cervical cancer remains. The newest addition to the list is the newest addition to the list, the newest addition to the list, the newest addition to the list.
The doctor reminds us that only regular testing can lead to early detection and timely treatment. The newest addition to the list is the newest addition to the list, the newest addition to the list, the newest addition to the list.
This article is reprinted with permission from health news information network media - healthcare network
Topics: HPV, women, cervical cancer, smear test, medical technology